???global.info.a_carregar???
Catarina Gomes is a young female researcher, with 10 years of PostDoc experience in Glycobiology in Cancer field. Catarina holds a PhD in Biomedicine (Dec 2013) from the Faculty of Medicine University of Porto. Her PhD research was carried at Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), under the supervision of Dr. Celso A. Reis, with an international stay at the Center of Biochemistry, Cologne, Germany. Catarina performed a PostDoc at a world-leading laboratory in glycobiology, the Copenhagen Centre for Glycomics (CCG - Denmark), supervised by Prof. Dr. Henrik Clausen. At CCG Catarina´s made part of a team that developed a comprehensive library of gRNAs targeting all known glycoenzymes (Glycobiology 2018, and commercially available at Addgene), also she acquired solid expertise in glycosylation mechanisms and unique skills in relevant genetically engineered cell-based models of disease (Nature Methods 2018). Currently, Catarina is an Assistant Researcher at the Glycobiology in Cancer Group at i3S under the FCT Individual Call to Scientific Employment Stimulus (2022.04678.CEECIND) and a principal investigator of projects focused on new strategies for cancer drug discovery based on aberrant glycans expression in cancer. During her researcher career, Catarina enroll in relevant national and international courses such as Advanced Molecular Technology and Instrumentation for Proteome Analyses (Uppsala, Sweden, 2015), summer schools of Advanced Science on Mass Spectrometry-based Proteomics (Sao Paulo, Brazil, 2017) and course in laboratory animal science Felasa C (Porto, Portugal, 2018). Catarina has been participating in several research projects financed both by national and international institutions. Also, Catarina has been participating in juries of MSc and PhD academic degrees, acting as ah-hoc reviewer for international peer-reviewed journals and expert evaluator of international research programs (e.g. Dioscuri Programme from Max Planck Society). Since 2018, Catarina has been focused in establishing her new research line at i3S on the development of new strategies for cancer drug discovery based on cancer-associated alterations of glycosylation. For that, she has been successful in secure financial support, 2018 FCT funded project (225.417€, PTDC/MED-QUI/29780/2017) and 2021 FCT funded project (249.810€, PTDC/MED-QUI/2335/2021) that permitted the establishment of a motivated research team. Catarina future ambition is to perform investigation with potential to translate into clinically meaningful data and improving cancer patient´s lives.
Read full resume ↓
Identification

Personal identification

Full name
Catarina de Sena Bastos Gomes

Citation names

  • Gomes, Catarina

Author identifiers

Ciência ID
4416-3B04-71EF
ORCID iD
0000-0002-0352-6783
Google Scholar ID
https://scholar.google.com/citations?hl=pt-PT&user=lxu-n1AAAAAJ
Researcher Id
AAU-4636-2020
Scopus Author Id
15069060000

Email addresses

  • cgomes@ipatimup.pt (Professional)

Addresses

  • R. Alfredo Allen, 4200-135, Porto, Porto, Portugal (Professional)
  • Travessa da residência Nº7, 4715-100, Braga, Braga, Portugal (Personal)

Websites

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Medicinal Chemistry
  • Medical and Health Sciences - Health Sciences

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Education
Degree Classification
2023
Concluded
 Bioquímica (Mestrado)
Major in Sem especialização
Universidade do Porto Faculdade de Ciências, Portugal
"Establishment of a CRISPR/Cas9 activation (CRISPRa) methodology to study the role of Sialyl Lewis X expression in malignant features of gastrointestinal cancer cells" (THESIS/DISSERTATION)
 20
2018/06/18 - 2018/06/22
Concluded
 Course on High Throughput Screening and Image Analysis for BioSciences (Curso de Especialização Tecnológica)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2018/05/07 - 2018/05/18
Concluded
 Course in laboratory animal science, Felasa Category C (Pós-Graduação)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2017/08/28 - 2017/09/06
Concluded
 summer school: Sao Paulo School of Advanced Science on Mass Spectrometry-based Proteomics (SPSAS-MS) (Curso de Especialização Tecnológica)
Centro Nacional de Pesquisa em Energia e Materiais, Brazil
2015/08/31 - 2015/09/10
Concluded
 Course on Advanced Molecular Technology and Instrumentation for Proteome Analyses (Curso de Especialização Tecnológica)
SciLifeLab, Sweden
2013/12/13
Concluded
 Biomedicina (Doutoramento)
Major in Biomedicine
Universidade do Porto Faculdade de Medicina, Portugal
"Discovery of novel biomarkers in gastric cancer based on post-translational modifications of glycoproteins" (THESIS/DISSERTATION)
 Approved with Distinction
2004/09/01 - 2008/12/05
Concluded
 Biologia Aplicada (Licenciatura)
Universidade do Minho, Portugal
"Discovery of novel serum biomarkers for early detection of gastric cancer" (THESIS/DISSERTATION)
 16 - 20
Affiliation

Science

Category
Host institution 		Employer
2023/03/01 - Current Auxiliary Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2018/11/01 - 2023/02/28 Contracted Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2014/05/01 - 2018/10/31 Postdoc (Research) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2016/01/01 - 2017/01/01 Postdoc (Research) Copenhagen Center for Glycomics – University of Copenhagen, Denmark
2009/11/01 - 2010/03/01 Visiting Researcher (Research) Institut für Biochemie II, Germany
Medical Faculty, University of Cologne, Germany
2008/01/01 - 2008/08/31 Research Trainee (Research) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Others

Category
Host institution 		Employer
2013/04/01 - 2014/04/01 Bolseiro de investigação Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2009/01/01 - 2012/12/31 PhD student Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Projects

Grant

Designation Funders
2024/01/01 - Current GLYCO_BRIDGE: Bridging skills in glycosciences to leap forward cancer glycobiology knowledge
2023.09792.CBM
Institut de Biologie Structurale, France

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia

Campus France
Ongoing
2014/05/01 - 2018/10/31 Characterization of glycosylation alterations in Carcinoembryonic antigen (CEA) and Plasminogen in gastric cancer and development of new glycan-based assays for diagnostic applications
SFRH/BPD/96510/2013
Post-doc Fellow
Fundação para a Ciência e a Tecnologia
Concluded
2013/04/01 - 2014/03/31 The role of sialylation in modulating galectin-3 functions in the metastatic process of canine mammary tumours
PTDC/CVT/117610/2010
Research Fellow
Concluded
2009/01/01 - 2012/12/31 Discovery of novel serum biomarkers in gastric cancer for early diagnosis, based on post-translational modifications of o-glycoproteins
SFRH/BD/44236/2008
PhD Student Fellow
Universidade do Porto Faculdade de Medicina, Portugal
 FCT- Fundação para a Ciência e Tecnologia
Concluded

Contract

Designation Funders
2023/02/01 - Current Erbb2 Molecular hEterogeneity dRives Glycan-mEdiated trastuzumab resistaNCE
2022.04138.PTDC
Co-Principal Investigator (Co-PI)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2022/05/27 - Current COST ACTION 18103 - Innovation with Glycans: new frontiers from synthesis to new biological targets
COST ACTION 18103
Researcher
Ongoing
2022/01/01 - Current Exploring glycans as novel players in tumor-adipose tissue transdifferentiation and cancer cachexia
EXPL/MED-ONC/1001/2021
Researcher
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2022/01/01 - Current Glycotarget. A new frontier in extracellular vesicle-mediated cancer immunomodulation
PTDC/MEC-ONC/0491/2021
Researcher
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2022/01/01 - Current Glycan-defined organoids as gastric cancer avatars for patient stratification and prediction of therapeutic response
EXPL/BTM-ORG/1450/2021
Researcher
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2022/01/01 - Current SweetKiller: Monosaccharide analogues as novel therapeutic agents to block glycan-driven cancer cell metastasis.
PTDC/MED-QUI/2335/2021
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

FCiênciasID Associação para a Investigação e Desenvolvimento de Ciências, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2023/02/01 - 2029/01/31 Unsweetening the cancer cell glycome: fluorinated monossacharide as a new tool and therapeutic approach for gastric cancer
2022.04678.CEECIND/CP1735/CT0008
10.54499/2022.04678.CEECIND/CP1735/CT0008
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2022/01/01 - 2025/12/31 SweetKiller: Monosaccharide analogues as novel therapeutic agents to block glycan-driven cancer cell metastasis.
PTDC/MED-QUI/2335/2021
10.54499/PTDC/MED-QUI/2335/2021
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

FCiênciasID Associação para a Investigação e Desenvolvimento de Ciências, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2021/01/01 - 2025/12/31 Institute for Research and Innovation in Health
LA/P/0070/2020
10.54499/LA/P/0070/2020
Instituto de Astrofísica e Ciências do Espaço, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/07/01 - 2022/02/28 GastroCure - Bioactive Soybean and Cruciferous extracts towards application in gastrointestinal disorders: development, characterization and delivery
PTDC/BAA-AGR/32094/2017
Researcher
Universidade Católica Portuguesa, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/07/26 - 2022/01/25 Targeting the cancer cell and extracellular matrix glycan's dynamics for impairment of tumour progression
PTDC/MED-ONC/28489/2017
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/07/01 - 2021/12/31 Identification of Novel GlycoSpecific Drugs to Tackle Cancer Cell Metastasis
PTDC/MED-QUI/29780/2017
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2019/01/01 - 2019/12/31 Institute for Research and Innovation in Health Sciences
UID/BIM/04293/2019
Instituto de Astrofísica e Ciências do Espaço, Portugal

Universidade do Porto, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2016/05/01 - 2019/12/31 Glycosylation of tyrosine kinase receptors as novel biomarkers for targeted therapy.
NORTE-01-0154-FEDER-000029
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 NORTE2020
Ongoing
2012/01/01 - 2014/06/30 Glycomic Approach to unravel the role of Glycostructures in Gastric Carcinogenesis
gkghçkmn987
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Institut Mérieux
Concluded
2011/01/01 - 2012/12/31 Projecto Estratégico - LA 3 - 2011-2012
PEst-C/SAU/LA0003/2011
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2009/01/01 - 2012/03/31 Early detection of cancer using serum biomarkers based on aberrant post-translational modifications of O-glycoproteins, O-PTM-Biomarkers.
PIC/IC/82716/2007
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2009/01 - 2012/03 Early detection of cancer using serum biomarkers based on aberrant post-translational modifications of O-glycoproteins, O-PTM-Biomarkers.
grant.Provided by PTCRIS: 82716
Researcher
Fundação para a Ciência e a Tecnologia

Other

Designation Funders
2018/11/01 - 2024/10/31 Not available
DL 57/2016/CP1363/CT0004
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
Outputs

Publications

Conference poster
  1. Costa, Ana Filipa; Hamala, Vojtech; Senra, Emanuel; Teixeira, Andreia; Abrantes, Rafaela; Isabel Faria-Ramos; Celso Reis; Karban, Jindrich; Gomes, Catarina. "4F-GalNAc as a novel inhibitor of cancer-associated O-glycans in gastrointestinal cancer cells.". Paper presented in International SialoGlyco meeting, 2024.
  2. Marques, Catarina; Ribeiro, Ana Raquel; Gomes, Catarina; Poças, Juliana; Faria-Ramos, Isabel; Reis, Celso A.; Vivès, Romain; Magalhães, Ana. "Decoding Heparan Sulfate unique structural epitopes involved in cancer cell signalling". Paper presented in EDCSV PhD Day 2023 at the Maison de la Création et de l'Innovation (Grenoble,France), 2023.
  3. Ribeiro, Ana Raquel; Marques, Catarina; Gomes, Catarina; Faria-Ramos, Isabel; Reis, Celso A.; Duarte, Henrique O.; Magalhães, Ana. "Compreender o impacto da glicosilação com Heparano Sulfato na modulação da atividade de Recetores Tirosina Cinase em cancro". Paper presented in ENJIO - 5º Encontro Nacional de Jovens Investigadores em Oncologia, 2023.
  4. Costa, Ana Filipa; Senra, Emanuel; Abrantes, Rafaela; Isabel Faria-Ramos; Celso Reis; Karban, Jindrich; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Fluorinated GalNAc as a novel inhibitor of cancer-associated O-glycans in gastrointestinal cancers". Paper presented in Carbohydrates Gordon Research Conference: Basic and Translational Glycoscience for Human Health and Diseases, 2023.
  5. Senra, Emanuel; Costa, Ana Filipa; Abrantes, Rafaela; Isabel Faria-Ramos; Celso Reis; Karban, Jindrich; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Fluorinated GalNAc as a novel inhibitor of cancer-associated O-glycans in gastrointestinal cancer". Paper presented in 15th Jenner Glycobiology and Medicine Symposium, 2023.
  6. Abrantes, Rafaela; Christopher Forcados; Senra, Emanuel; Costa, Ana Filipa; David Warren; Gomes, Catarina; Else Marit Inderberg; walchli, sebastien; Celso Reis. "Development of novel CAR-Ts directed to tumor-associated glycoepitopes". Paper presented in 15th Jenner Glycobiology and Medicine Symposium, 2023.
  7. Marques, Catarina; Poças, Juliana; Gomes, Catarina; Ribeiro, Ana Raquel; Faria-Ramos, Isabel; Reis, Celso A.; Vivès, Romain; Magalhães, Ana. "Heparan Sulfate glycosyltransferases remodel the cell glycoproteome and shape gastric cancer aggressive features". Paper presented in 15th Jenner Glycobiology and Medicine Symposium at i3S (Porto, Portugal), 2023.
  8. Teixeira-Castro, Andreia; Senra, Emanuel; Costa, Ana Filipa; Isabel Faria-Ramos; Celso Reis; Magalhães, Ana; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Establishment of a CRISPR/Cas9 activation (CRISPRa) methodology to study Sialyl Lewis X role in malignant features of gastrointestinal cancer". Paper presented in Investigação Jovem da Universidade do Porto (IJUP), 2023.
  9. Costa, Ana Filipa; Senra, Emanuel; Abrantes, Rafaela; Isabel Faria-Ramos; Celso Reis; Karban, Jindrich; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Fluorinated GalNAc as a novel inhibitor of cancer-associated truncated O-glycans in gastrointestinal cancer". Paper presented in 29th Porto Cancer Meeting, 2023.
  10. Costa, Ana Filipa; Senra, Emanuel; Abrantes, Rafaela; Isabel Faria-Ramos; Celso Reis; Karban, Jindrich; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Fluorinated GalNAc as a novel inhibitor of cancer-associated O-glycans in gastrointestinal cancers". Paper presented in Young Researchers on stage: International Meeting of Young Researchers – INNOGLY & GLYCONanoPROBES: Sour Turned Sweet: Glycans Bridging Technology and Precision Medicine, 2023.
  11. Teixeira-Castro, Andreia; Senra, Emanuel; Costa, Ana Filipa; Isabel Faria-Ramos; Reis, Celso; Magalhães, Ana; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Establishment of a CRISPR/Cas9 activation (CRISPRa) methodology to study Sialyl Lewis X role in malignant features of gastrointestinal cancer". Paper presented in VII Jornadas da Bioquímica, FCUP, 2023.
  12. Costa, Ana Filipa; Senra, Emanuel; Abrantes, Rafaela; Reis, Celso; Karban, Jindrich; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Fluorinated GalNAc as a novel inhibitor of cancer-associated truncated O-glycans in gastrointestinal cancer". Paper presented in 9th MCBiology symposium, 2023.
  13. Marques, Catarina; Poças, Juliana; Gomes, Catarina; Ribeiro, Ana Raquel; Faria-Ramos, Isabel; Reis, Celso A.; Vivès, Romain; Magalhães, Ana. "Heparan Sulfate biosynthetic pathway: understanding the GAGosylation road that leads to gastric cancer progression". Paper presented in 5th PhDay: Building Paths, The ScienceBehind Us at i3S (Porto, Portugal), 2022.
  14. Costa, Ana Filipa; Senra, Emanuel; Diana campos; Joana Gomes; Marta Teixeira Pinto; Maia, André; Pombinho, António; Celso Reis; Gomes, Catarina. Corresponding author: Gomes, Catarina. "High throughput screening of chemical compounds showed monensin as novel cancer drug by inhibiting SLeX expression and malignant properties in gastrointestinal cancer cells". Paper presented in 30th International Carbohydrate Symposium (ICS2022), 2022.
  15. Joao Morais; Ana F Costa; Celso A Reis; Catarina Gomes. Corresponding author: Catarina Gomes. "Biological impact of SLeX expression in gastrointestinal cancers". Paper presented in 14º Edição Encontro de Investigação Jovens UP, 2021.
  16. Ferreira, Liliana; Gomes, Catarina; Reis, Celso; Pinto, Filipe. "The small leucine-rich repeat proteoglycan biglycan is a negative prognostic factor of gastric cancer by modulation of cell death/survival". Paper presented in CANCER BIOLOGY: FROM BASIC TO TRANSLATIONAL RESEARCH webinar - Liga Portuguesa Contra o Cancro, 2020.
  17. Diniz, Francisca; Sousa, Flávia; Campos, Diana; Gomes, Catarina; Gomes, Joana; Sarmento, Bruno; Reis, Celso A.. "Sistema inovador de nanoentrega usando glicanos para entrega direcionada em cancro". Paper presented in 2º Encontro Nacional de Jovens Investigadores em Oncologia, 2020.
  18. Ana Costa; Diana Campos; Rafaela Abrantes; Celso A. Reis; Catarina Gomes. "Establishment of a CRISPR-Cas9 glycoengineered cell line model for high throughput screenings". Paper presented in 13th International Meeting of the Portuguese Carbohydrate Group – GLUPOR 13, 2019.
  19. Gomes C; Almeida A; Osório H; Barreira AC; Santos-Sousa H; Pinto-de-Sousa J; Kolarich D; Reis CA. "Carcinoembryonic antigen carries a2-3 linked sialic acid on type II chains and is implicated in the metastatic potential of gastric cancer cells". Paper presented in BENZON Symposium Nº64: glycotherapeutics – emerging roles of glycans in medicine, 2018.
  20. Gomes, Catarina; Andreia Almeida; Ana Cintia Barreira; Hugo Osório; Hugo Santos-Sousa; João Pinto-de-Sousa; Daniel Kolarich; Celso A. Reis. Corresponding author: Gomes, Catarina. "Carcinoembryonic antigen carries a2-3 linked sialic acid on type II chains and is implicated in the metastatic potential of gastric cancer cells". Paper presented in ao Paulo School of Advanced Science on Mass Spectrometry-based Proteomics (SPSAS-MS), 2017.
  21. Gomes, Catarina. "Identification of SLeX expressing proteins in gastric carcinoma: possible role in cancer cell invasion and metastasis". Paper presented in XXIII International Symposium on Glycoconjugates (GLYCO 23), 2015.
  22. Gomes, Catarina; Hugo Osório; Marta T Pinto; Celso A. Reis. "Overexpression of ST3Gal-IV induces activation of cell signaling pathways and alteration in gastric cancer cell line phenotype.". Paper presented in joint meeting of the Society for Glycobiology and American Society for Matrix Biology San Diego, 2012.
  23. Gomes, Catarina; Hugo Osório; Marta T Pinto; Celso A. Reis. "Role of SLea and SLex in gastric cancer cells". Paper presented in GLYCOT Hannover 2012: 8th International Symposium on Glycosyltransfrases, 2012.
  24. Gomes, Catarina. "Glycan biomarkers in gastric lesions: tissue and serum characterization". Paper presented in GLYCO 21: XXI International Symposium on Glycoconjugates, August 21-26, 2011 Vienna, Austria, 2011.
    h10.1007/s10719-015-9596-4
  25. Gomes, Catarina. "Serum glycoprotein biomarkers in gastric carcinoma patients". Paper presented in ANNUAL CONConference of the SOCIETY FOR GLYCOBIOLOGY, November 7 – 10, 2010 TradeWinds Island Grand Resort, St. Pete Beach, FL, USA, 2010.
    10.1093/glycob/cwq141
  26. Gomes, Catarina; M. Luísa S. Silva; Celso A. Reis; Leonor David; Hugo Osório. "Detection of cancer-associated proteins as potential biomarkers, using a proteomics approach". Paper presented in 5th Congress of the Portuguese Proteomics Network - ProCura and 1st International Congress on Analytical Proteomics – ICAP, 2009.
Journal article
  1. Costa, Ana F.; Teixeira, Andreia; Reis, Celso A.; Gomes, Catarina. "Novel anticancer drug discovery efforts targeting glycosylation: the emergence of fluorinated monosaccharides analogs". Expert Opinion on Drug Discovery (2025): 1-11. https://doi.org/10.1080/17460441.2024.2444375.
    Open access • Published • 10.1080/17460441.2024.2444375
  2. Costa-Barbosa, Augusto; Ferreira, Diogo; Pacheco, Maria Inês; Casal, Margarida; Duarte, Henrique Oliveira; Gomes, Catarina; Barbosa, Ana Margarida; et al. "Candida albicans chitinase 3 with potential as a vaccine antigen: Production, purification and characterisation". Biotechnology Journal (2023): 2300219. https://onlinelibrary.wiley.com/doi/full/10.1002/biot.202300219.
    Published • 10.1002/biot.202300219
  3. Ana F. Costa; Emanuel Senra; Isabel Faria-Ramos; Andreia Teixeira; João Morais; Mariana Pacheco; Celso A. Reis; Catarina Gomes. Corresponding author: Catarina Gomes. "ST3GalIV drives SLeX biosynthesis in gastrointestinal cancer cells and associates with cancer cell motility". Glycoconjugate Journal (2023): https://doi.org/10.1007/s10719-023-10113-y.
    10.1007/s10719-023-10113-y
  4. Poças, Juliana; Marques, Catarina; Gomes, Catarina; Otake, Andreia Hanada; Pinto, Filipe; Ferreira, Mariana; Silva, Tiago; et al. "Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival". Proceedings of the National Academy of Sciences 120 20 (2023): http://dx.doi.org/10.1073/pnas.2214853120.
    10.1073/pnas.2214853120
  5. C Marques; J Poças; C Gomes; I Faria-Ramos; C A. Reis; R R. Vivès; A Magalhães. Corresponding author: A Magalhães. "Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion". Journal of Biological Chemistry (2022): https://doi.org/10.1016/j.jbc.2022.102546.
    10.1016/j.jbc.2022.102546
  6. Abrantes R; Duarte HO; Gomes C; Walchli S; Reis CA. Corresponding author: Reis CA. "CAR-Ts: new perspectives in cancer therapy". FEBS Letters (2022): https://doi.org/10.1002/1873-3468.14270.
    10.1002/1873-3468.14270
  7. N Brito- Santos; J S. Yount; Z Vaz da Silva; Gomes, Catarina; C A. Reis; M J Amorim. Corresponding author: M J Amorim. "Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology". PLOS Pathogens (2021): https://doi.org/10.1371/journal.ppat.1009381.
    10.1371/journal.ppat.1009381
  8. Pinto F; Santos-Ferreira L; Pinto M; Gomes C; Reis CA. Corresponding author: Reis CA. "The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness". Cancers 13 6 (2021): 1330-1330. https://doi.org/10.3390/cancers13061330.
    10.3390/cancers13061330
  9. Rodrigues JG; Duarte HO; Gomes C; Balmaña M; Martins AM; Hensbergen JG; de Ru AH; et al. "Terminal a2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells". Cellular Oncology (2021):
    Accepted
  10. Duarte HO; Rodrigues J.G; Gomes C; Hensbergen PJ; Hipgrave Edervee AL; de Ru, A.H; Mereiter S; et al. "ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab". oncogene (2021):
    Accepted
  11. Costa AF; Campos D; Reis CA; Gomes, Catarina. Corresponding author: Gomes, Catarina. "Targeting Glycosylation: A New Road for Cancer Drug Discovery". Trends in Cancer 6 9 (2020): 757-766. http://dx.doi.org/10.1016/j.trecan.2020.04.002.
    10.1016/j.trecan.2020.04.002
  12. Moreira IB; Campos D; Pinto F; Gomes C; Reis CA. "Impact of Truncated O-glycans in Gastric-Cancer-Associated CD44v9 Detection". Cells 9 2 (2020): 264. http://dx.doi.org/10.3390/cells9020264.
    10.3390/cells9020264
  13. Gomes C; Almeida A; Barreira A; Calheiros J; Pinto F; Abrantes R; Costa A; et al. Corresponding author: Gomes C. "Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas". Theranostics 9 24 (2019): 7431-7446. http://dx.doi.org/10.7150/thno.33858.
    Open access • Published • 10.7150/thno.33858
  14. Mereiter S.; Martins Á.M.; Gomes C.; Balmaña M.; Macedo J.A.; Polom K.; Roviello F.; Magalhães A.; Reis C.A.. "O-glycan truncation enhances cancer-related functions of CD44 in gastric cancer". FEBS Letters 593 13 (2019): 1675-1689. http://www.scopus.com/inward/record.url?eid=2-s2.0-85069969294&partnerID=MN8TOARS.
    Published • 10.1002/1873-3468.13432
  15. Narimatsu Y; Joshi H J; Yang Z; Gomes C; Chen YH; Lorenzetti F; Furukawa S; et al. "A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome". Glycobiology 28 5 (2018): 295-305. http://dx.doi.org/10.1093/glycob/cwx101.
    Published • 10.1093/glycob/cwx101
  16. Rodrigues, J.G.; Balmaña, M.; Macedo, J.A.; Poças, J.; Fernandes, Â.; de-Freitas-Junior, J.C.M.; Pinho, S.S.; et al. "Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis". Cellular Immunology 333 (2018): 46-57. http://www.scopus.com/inward/record.url?eid=2-s2.0-85044285887&partnerID=MN8TOARS.
    10.1016/j.cellimm.2018.03.007
  17. Chen, Y.-H.; Narimatsu, Y.; Clausen, T.M.; Gomes, C.; Karlsson, R.; Steentoft, C.; Spliid, C.B.; et al. "The GAGOme: a cell-based library of displayed glycosaminoglycans". Nature Methods 15 11 (2018): 881-888. http://www.scopus.com/inward/record.url?eid=2-s2.0-85052313120&partnerID=MN8TOARS.
    10.1038/s41592-018-0086-z
  18. Balmaña M; Duran A.; Gomes C.; Llop E.; López-Martos R.; Ortiz M.R.; Barrabés, S.; Reis C.A.; Peracaula R. "Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues". International Journal of Biological Macromolecules 112 (2018): 33-45. http://www.scopus.com/inward/record.url?eid=2-s2.0-85041805179&partnerID=MN8TOARS.
    10.1016/j.ijbiomac.2018.01.148
  19. S Silva, M Luisa; Gomes, Catarina; Quinaz Garcia, M Beatriz. "Flow Lectin Affinity Chromatography-A Model with Sambucus nigra Agglutinin". Journal of Glycobiology 06 01 (2017): http://dx.doi.org/10.4172/2168-958x.1000121.
    10.4172/2168-958x.1000121
  20. Duarte, H.O.; Freitas, D.; Gomes, C.; Gomes, J.; Magalhães, A.; Reis, C.A.. "Mucin-type O-glycosylation in gastric carcinogenesis". Biomolecules 6 3 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85012048870&partnerID=MN8TOARS.
    10.3390/biom6030033
  21. Mereiter S.; Magalhães A.; Adamczyk B.; Jin C.; Almeida, A.; Drici L.; Ibáñez-Vea M.; et al. "Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer". Biochimica et Biophysica Acta - General Subjects 1860 8 (2016): 1795-1808. http://www.scopus.com/inward/record.url?eid=2-s2.0-84952685671&partnerID=MN8TOARS.
    10.1016/j.bbagen.2015.12.016
  22. Gomes, Catarina. "Characterization of Sialidases Neu1, Neu2, and Neu4 in a Canine Model of Breast Cancer". Glycobiology Insights 6 (2016): 11-19. http://dx.doi.org/10.4137/gbi.s30034.
    10.4137/gbi.s30034
  23. De Oliveira J.T.; Ribeiro C.; Barros R.; Gomes C.; De Matos A.J.; Reis C.A.; Rutteman G.R.; Gärtner F.. "Hypoxia up-regulates galectin-3 in mammary tumor progression and metastasis". PLoS ONE 10 7 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84941687077&partnerID=MN8TOARS.
    10.1371/journal.pone.0134458
  24. De Oliveira J.T.; Santos A.L.; Gomes C.; Barros R.; Ribeiro C.; Mendes N.; De Matos A.J.; et al. "Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness". PLoS ONE 10 4 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84929484710&partnerID=MN8TOARS.
    10.1371/journal.pone.0121590
  25. Campos D.; Freitas D.; Gomes J.; Magalhães A.; Steentoft C.; Gomes C.; Vester-Christensen M.B.; et al. "Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery". Molecular and Cellular Proteomics 14 6 (2015): 1616-1629. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930470850&partnerID=MN8TOARS.
    10.1074/mcp.M114.046862
  26. Figueira A.C.; Gomes C.; Vilhena H.; Miranda S.; Carvalheira J.; De Matos A.J.F.; Dias-Pereira P.; Gärtner F .. "Characterization of a-, ß- and p120-Catenin expression in feline mammary tissues and their relation with E- and P-cadherin". Anticancer Research 35 6 (2015): 3361-3369. http://www.scopus.com/inward/record.url?eid=2-s2.0-84931437967&partnerID=MN8TOARS.
  27. Silva MLS; Gutiérrez E; Rodríguez JA; Gomes C; David L. "Construction and validation of a Sambucus nigra biosensor for cancer-associated STn antigen". Biosensors and Bioelectronics 57 (2014): 254-261. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896887425&partnerID=MN8TOARS.
    10.1016/j.bios.2014.02.006
  28. Figueira AC; Gomes C.; de Oliveira JT; Vilhena, H.; Carvalheira J.; de Matos A.J.F.; Pereira P.D.; Gartner F.. "Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas". BMC Veterinary Research 10 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84988960135&partnerID=MN8TOARS.
    10.1186/s12917-014-0270-z
  29. Gomes C; Almeida A; Ferreira JA; Silva L; Santos-Sousa H; Pinto-De-Sousa J; Santos LL; et al. "Glycoproteomic analysis of serum from patients with gastric precancerous lesions". Journal of Proteome Research 12 3 (2013): 1454-1466. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874635340&partnerID=MN8TOARS.
    10.1021/pr301112x
  30. Gomes C; Osório H; Pinto MT; Campos D.; Oliveira MJ; Reis CA. "Expression of ST3GAL4 Leads to SLexExpression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells". PLoS ONE 8 6 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84879165131&partnerID=MN8TOARS.
    10.1371/journal.pone.0066737
  31. Almeida A; Ferreira JA; Teixeira F.; Gomes C; Cordeiro M.ND.S.; Osório H; Santos LL; et al. "Challenging the limits of detection of sialylated Thomsen-Friedenreich antigens by in-gel deglycosylation and nano-LC-MALDI-TOF-MS". Electrophoresis 34 16 (2013): 2337-2341. http://www.scopus.com/inward/record.url?eid=2-s2.0-84881615874&partnerID=MN8TOARS.
    10.1002/elps.201300148
  32. Marcos, N.T.; Bennett, E.P.; Gomes, J.; Magalhaes, A.; Gomes, C.; David, L.; Dar, I.; et al. "ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues". Frontiers in Bioscience - Elite 3 E 4 (2011): 1443-1455. http://www.scopus.com/inward/record.url?eid=2-s2.0-80053586749&partnerID=MN8TOARS.
  33. Reis, C. A; Osorio, H.; Silva, L.; Gomes, C.; David, L.. "Alterations in glycosylation as biomarkers for cancer detection". Journal of Clinical Pathology 63 4 (2010): 322-329. http://dx.doi.org/10.1136/jcp.2009.071035.
    10.1136/jcp.2009.071035
Preprint
  1. Costa, Ana Filipa; Senra, Emanuel; Campos, Diana; Faria-Ramos, Isabel; Santos-Ferreira, Liliana; Lamas, Sofia; Gomes, Joana; et al. Corresponding author: Gomes, Catarina. "Monensin as potential drug for treatment of SLeX-positive tumors". 2024. http://dx.doi.org/10.1101/2024.03.11.24304048.
    10.1101/2024.03.11.24304048
Thesis / Dissertation
  1. Mariana de Sousa Pacheco. "Understand the Role of Glycans in the Oncogenesis of Pediatric Sarcomas". Master, 2024. https://hdl.handle.net/10216/163894.
  2. Andreia Castro Teixeira. "Establishment of a CRISPR/Cas9 activation (CRISPRa) methodology to study the role of Sialyl Lewis X expression in malignant features of gastrointestinal cancer cells". Master, 2023. https://hdl.handle.net/10216/155618.
  3. Rafaela Abrantes Baptista. "Role of carcinoembryonic antigen specific glycoform in Kupffer cell activation and cancer cell invasion". Master, 2019. https://hdl.handle.net/10216/125102.
  4. Ana Catarina Pais dos Santos Figueira. "Characterization of P-Cadherin in feline mammary tumours - Association with tumours aggressiveness". PhD, 2016. https://repositorio-aberto.up.pt/handle/10216/98301.
  5. Ana Cíntia Silva Barreira. "Role of carcinoembryonic antigen (CEA) glycosylation in gastric cancer". Master, 2015. https://repositorio-aberto.up.pt/handle/10216/82267.
  6. Catarina de Sena Bastos Gomes. "Discovery of novel biomarkers in gastric cancer based on post-translational modifications of glycoproteins". PhD, 2013. http://hdl.handle.net/10216/71170.
  7. Gomes, Catarina. ""Discovery of novel cancer serum biomarkers based on aberrant post-translational modifications of O-glycoproteins, O-PTM-Biomarkers, and their application to early detection of cancer". Degree, Universidade do Minho Departamento de Biologia, 2008.

Intellectual property

Patent
  1. Gomes, Catarina. 2013. "BIOMARCADORES SÉRICOS PARA DIAGNÓSTICO DO CANCRO DO ESTÔMAGO". Portugal.
    Expired
  2. Gomes, Catarina. 2013. "CO-EXPRESSÃO DE CEA E GLICANOS SLEX COMO BIOMARCADOR NO CANCRO GÁSTRICO".
    Expired
Provisional application for patent
  1. 2022. "Juliana Poças, Catarina Gomes, Celso A. Reis, Ana Magalhães. "SDC4 as a gastric cancer biomarker"".
    Protected
  2. 2022. "Ana Costa, Diana Campos, André Maia, António Pombinho, Celso A. Reis and Catarina Gomes. "Monensin for use in the treatment of gastrointestinal cancer through inhibition of SLeX expression and its associated malignant properties".".
    Protected

Other

Other output
  1. Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology. 2021. Nuno Brito Santos; Zoé Enderlin Vaz da Silva; Catarina Gomes; Celso A. Reis; Maria João Amorim. https://doi.org/10.1101/2021.02.16.431406.
    10.1101/2021.02.16.431406
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/02/24 Desvendar o papel da glicobiologia nos sarcomas pediátricos: abrir portas para novas estratégias terapêuticas. 10º Seminário de Oncologia Pediátrica
fundação Rui Osório de Castro (Lisboa, Portugal)
2024/01/15 Finely tuned glycoengineering to unravel cancer cell behavior and test new glycan drugs 7th iberian carbohydrate meeting
GLUPOR-SPQ and GE HiC-RSEQ (barcelona, Spain)
2023/11/23 Monensin disrupts the synthesis of slex in tumors and influences its malignant features: a promising therapeutic option Glycobasque 6
CIC bioGUNE (Bilbao, Spain)
2023/06/19 Monensin disrupts the synthesis of SLeX in tumors and influences its malignant features: a promising therapeutic option Basic and Translational Glycoscience for Human Health and Diseases
Carbohydrates Gordon Research Conference (New Hampshire, United States)
2023/06/14 Monensin disrupts the synthesis of SLeX in tumors and influences its malignant features 15th Jenner Glycobiology and Medicine Symposium
i3S and the Royal Society of Medicine (Porto, Portugal)
2023/05/11 Monensin disrupts the synthesis of SLeX in tumors and influences its malignant features XXIX PORTO CANCER MEETING
i3S (Porto, Portugal)
2023/03/29 Sweet roads for therapy development in cancer Jornadas de Biotecnologia 2023
Universidade Católica do Porto (Porto, Portugal)
2023/01/17 High throughput screening of chemical compounds showed monensin as novel cancer drug by inhibiting SLeX expression and malignant properties in gastrointestinal cancer cells 14th International Meeting of the Portuguese Carbohydrate Group – GLUPOR 14
School of Science and Technology, NOVA University of Lisbon (lisbon)
2023/01 Fluorinated GalNAc as a novel inhibitor of cancer-associated truncated O-glycans in gastrointestinal cancer 14th International Meeting of the Portuguese Carbohydrate Group (GLUPOR 14)
NOVA School of Science and Technology, NOVA University of Lisbon (Lisboa, Portugal)
2021/09/24 Análogos fluorados do monossacarídeo GalNAc como potenciais inibidores da biossíntese do antigénio tumoral STn 3º ENCONTRO NACIONAL DE JOVENS INVESTIGADORES EM ONCOLOGIA
Liga Portuguesa Contra o Cancro (porto, Portugal)
2020/11/16 "Glycosylation in Cancer: focus on gastric carcinogenesis" III semana NEBUP
University of Porto Faculty of Sciences
2019/09/05 Decipher the role of Sialyl Lewis X in gastric cancer cell metastization towards a target therapy development GLUPO 13
SPQ - Sociedade Portuguesa de Química (Portugal)
2017/12/13 Carcinoembryonic antigen altered glycosylation in gastric cancer i3S PostDoc seminar
(Porto, Portugal)
2017/09/11 Carcinoembryonic antigen carries a2-3 linked sialic acid on type II chains and is implicated in the metastatic potential of gastric cancer cells 12 International Meeting of the Portuguese Carbohydrate Group (GLUPOR 12)
SPQ - Sociedade Portuguesa de Química (Aveiro, Portugal)
2017/09 The role of glycosylation in the modulation of cancer cell aggressiveness 24th International Symposium On Glycoconjugates
(Jesu, South Korea)
2017/08/28 Carcinoembryonic antigen carries a2-3 linked sialic acid on type II chains and is implicated in the metastatic potential of gastric cancer cells Sao Paulo School of Advanced Science on Mass Spectrometry-based Proteomics (SPSAS-MS)
Brazilian Center for Research in Energy and Materials (CNPEM) (sao paulo, Brazil)
2017/04/05 Glycosylation alterations in cancer: impact on cancer cell behavior and biomarker discovery. Unidade de Investigação em Patobiologia Molecular IPO Lisboa
(Lisbon, Portugal)
2016/11 The role of the glycoproteome alterations in gastric cancer and its clinical applications Meeting Of The Society For Glycobiology
(New Orleans, United States)
2016/06 Glycosyltransferases in Cancer: the role in gastric carcinogenesis and in cancer progression 10th International Symposium on Glycosyltransferases (GlycoT 2016)
(Toronto, Canada)
2014/06/18 Expression of ST3GAL4 leads to SLeX expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells 9th International Symposium on Glycosyltransferases,
International Glycoconjugate Organization (IGO)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2022/09/01 - Current Disclosing the glycosylation profile of pediatric sarcomas as a source for novel biomarkers
Supervisor
 Medicine and molecular oncology (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2021/02/01 - Current GLYCO CAR-Ts: Development of novel immune-based cancer therapy directed to tumour-associated glycoepitopes
Co-supervisor of Rafaela Abrantes Baptista
 Programa Doutoral em Ciências Biomédicas (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/01/01 - Current Development of CEA-targeting nanoparticles loaded with deoxoflurinated monosaccharide analogues to tackle cancer cell metastasis
Supervisor of Ana Filipa da Silva Costa
 Programa doutoral em Biologia Molecular e Celular (PhD)
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2023 - 2023 Establishment of a CRISPR/Cas9 activation (CRISPRa) methodology to study the role of Sialyl Lewis X expression in malignant features of gastrointestinal cancer cells
Supervisor
 Bioquímica (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2022 - 2022 Establishment of glycoengineered cellular models to evaluate the capacity of monosaccharide analogues in blocking the biosynthesis of cancer-associated glycans
Supervisor
 Genética Molecular (Master)
Universidade do Minho, Portugal
2020/09/23 - 2021/07/31 Role of SLeX expression in gastrointestinal cancer
Supervisor of João Pedro da Costa Festa e Ventura Morais
 Licenciatura em Biologia (Degree)
Universidade do Porto Faculdade de Ciências, Portugal
2021 - 2021 Fluorinated monosaccharides as novel drugs to tackle cancer cell metastasis
Supervisor
 Biologia Molecular e Celular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019 - 2019 Role of carcinoembryonic antigen specific glycoform in Kupffer cell activation and cancer cell invasion
Co-supervisor
 Bioquímica (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2015 - 2015 Role of carcinoembryonic antigen (CEA) glycosylation in gastric cancer
Supervisor
 Bioquímica (Master)
Universidade do Porto Faculdade de Ciências, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2023/06/14 - 2023/06/16 15th Jenner Glycobiology and Medicine Symposium from the Royal Society of Medicine (2023/06/14 - 2023/06/16)
Symposium (Member of the Organising Committee)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023/05/11 - 2023/05/12 29th Porto Cancer Meeting (2023/05/11 - 2023/05/12)
Conference (Member of the Organising Committee)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2019/06/05 - 2019/06/07 Workshop on Genome Editing Using CRISPR-Cas9. (2019/06/05 - 2019/06/07)
Workshop (Member of the Organising Committee)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2024/05 - 2024/05 Pint of Science is a non-profit association whose main objective is to make scientific discussion accessible to the entire population in order to bridge the communication gap that exists in this area. To this end, an international science festival is held annually, where researchers from different areas are invited to present their projects in a simple and interesting way in a relaxed environment. The festival takes place annually for 3 days in the month of May and simultaneously in hundreds of cities around the world.
Round table
 Pint of Science
2024/04 - 2024/04 We create bridges between children and scientists across the country by holding unique and dynamic science workshops.
Workshop
 Native scientists: Cientista Regressa à Escola (Same Home Town Programme)

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2022 Genetic alterations in coding region of the CDH1 and CDH1-targeted miRNA expression in canine gastric cancer
(Thesis) Main arguer
 Ana Rute Ribeiro Teixeira Flores (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/07/09 Characterization of mesothelioma-associated fibroblasts and their contribution to growth and invasion of malignant pleural mesothelioma
(Thesis) Main arguer
 Maria Inês Marçal Nunes (Other)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/12/15 Establishment of a LRP1B-Knockout Human Cancer Cell Line Model with a CRISPR/Cas9 Approach
(Thesis) Main arguer
 Catarina Príncipe Ferreira dos Santos (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2020 The epitranscriptome in gastric cancer: the role of m6A mRNA modifications
(Thesis) Main arguer
 Luís Filipe Costa Póvoas (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2015 Glycoproteomic Characterization of Bladder Cancer Chemoresistant Cells
(Thesis) Main arguer
 Diogo André Teixeira Neves (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2012 Characterization of P-Cadherin in feline mammary tumours – Association with tumours aggressiveness
(Thesis) Arguer
 Ana Catarina Pais dos Santos Figueira (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Ad Hoc journal article review

Journal title (ISSN) Publisher
2023/11/20 - Current Trends in Cancer cell press
2021/03 - Current STAR Protocols Cell press
2020/11/11 - Current Applied sciences (2076-3417) MDPI
2020/07/21 - Current Cancers (2072-6694) MDPI
2020/06/04 - Current Glycoconjugate journal (1573-4986) Springer
2018/08 - Current International Journal of Cancer (1097-0215) Wiley (John Wiley & Sons)
2018/07 - Current Molecular Oncology (1878-0261) Wiley (John Wiley & Sons)
2016/05 - Current Biology (2079-7737) MDPI
2016/04 - Current Carbohydrate Polymers (0144-8617) Elsevier
2015/05 - Current BMC Cancer (1471-2407) Springer (Biomed Central Ltd.)

Association member

Society Organization name Role
2010 - Current Society for Glycobiology membership

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2016 - Current Post-graduate course of the University of Porto GABBA Module of Oncobiology (Doutoramento) Universidade do Porto, Portugal
2016 - Current Post-graduate course in Medicine (MIMED) UCO - "Protein Biomarkers in cancer: molecular basis and diagnosis & therapeutic applications" (1° Ciclo Medicina) (Licenciatura) Universidade do Porto Faculdade de Medicina, Portugal

Evaluation committee

Activity description
Role 		Institution / Organization Funding entity
2021/09/23 - Current Expert grant evaluator Dioscuri Programme - Max Planck Society
Evaluator
 Max-Planck-Gesellschaft Forschungsservice, Germany Max-Planck-Gesellschaft Forschungsservice
2022/10/03 - 2022/10/04 Abstract evaluator for the 5th PhDay: Building Paths, The Science Behind Us
Evaluator
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2019/09/03 - 2019/09/05 Poster evaluator for the 13th International Meeting of the Portuguese Carbohydrate group Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2019/09 - 2019/09 13th Meeting of the Portuguese Carbohydrate Group (GLUPOR 13): Selection scientific works and Evaluation of best poster
Evaluator
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Interview (newspaper / magazine)

Activity description Newspaper / Forum
2018/09/18 Cancro: Como travar o processo de metastização à distância? interview of a series of COMPETE 2020 projects

Journal scientific committee

Journal title (ISSN) Publisher
2023/03/01 - Current Frontiers in Bioengineering and Biotechnology

Mentoring / Tutoring

Topic Student name
2024/02/01 - Current Research Technician PTDC/MED-QUI/2335/2021 Andreia Castro Teixeira
2022/09/16 - 2023/10/15 Junior Researcher PTDC/MED-QUI/2335/2021 Isabel Antuness
2019/01/01 - 2021/12/16 Junior Researcher PTDC/MED-QUI/29780/2017 Diana Campos
2019/01/01 - 2020/12/31 Research Fellow PTDC/MED-QUI/29780/2017 Ana Filipa Costa

Other jury / evaluation

Activity description Institution / Organization
2024/01 - 2024/02 Member of the juri for an international selection tender procedure for PhD student under the scope of the MSCA-DN GlyCanDrug: Synthetic approaches for targeting cancer glycosylation
2024 - 2024 President of the furi for an international call for the selection of a researcher technician Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2022 - 2022 President of the Juri for an international selection tender procedure for doctoral hiring Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2022 - 2022 Member of the juri for an international selection tender procedure for doctorate hiring Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2021 - 2021 Member of the furi for an international call for the selection of a researcher technician
2018 - 2018 President of the Juri for an international selection tender procedure for doctoral hiring Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2018 - 2018 President of the furi for an international call for the selection of a research fellow Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Distinctions

Award

2023 Best oral communication
The Royal Society of Medicine, United Kingdom
2017 grant to attend Sao Paulo School of Advanced Science on Mass Spectrometry-based Proteomics (SPSAS-MS) (grant #2016/18802-4, FAPESP)
2015 XXIII International Symposium on Glycoconjugates (GLYCO 23) Travel award
2012 Symposium on Glycosyltransfrases travel award
2011 XXI International Symposium on Glycoconjugates (GLYCO 21) travel award
2010 Society for Glycobiology Travel award, St Petersburg Florida

Other distinction

2023 Prémio Rui Osório de Castro
Millennium bcp, Portugal
2018 Glycobiology paper editor's choice
Society of Glycobiology, United States